Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
2.
BMJ Paediatr Open ; 5(1): e001174, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34423141

RESUMEN

Many paediatric kidney transplant programmes were closed during the COVID-19 pandemic, and due to the vulnerable nature of patients with end-stage kidney disease (ESKD), there were new concerns once these programmes reopened. We surveyed children and families who received a kidney transplant during the pandemic. We found that half of the participants felt scared and/or anxious about receiving a kidney transplant during the pandemic, and 2/8 participants were worried about catching COVID-19 during their recovery. While detailed counselling and additional safety precautions contributed to a good experience, patients and parents still demonstrated fear towards transplantation.


Asunto(s)
COVID-19 , Fallo Renal Crónico , Trasplante de Riñón , Niño , Humanos , Fallo Renal Crónico/epidemiología , Trasplante de Riñón/efectos adversos , Pandemias , SARS-CoV-2
4.
Pediatr Nephrol ; 32(5): 879-884, 2017 05.
Artículo en Inglés | MEDLINE | ID: mdl-28039534

RESUMEN

BACKGROUND: New-onset diabetes after transplantation (NODAT) is a significant co-morbidity following kidney transplantation. Lower post-transplant serum magnesium levels have been found to be an independent risk factor for NODAT in adult kidney transplant recipients. METHODS: We undertook a retrospective analysis of risk factors for NODAT in pediatric renal transplant recipients at our institution with the aim of determining if hypomagnesemia confers a significant risk of developing NODAT in this patient population. RESULTS: A total of 173 children with a median age at transplantation of 7.0 (range 1.3-17.5) years were included. Hypomagnesemia was found to be a significant independent risk factor for NODAT (p = 0.01). High trough tacrolimus levels were also independently associated with NODAT (p < 0.001). There was no significant association between NODAT and body mass index at the time of transplantation, monthly cumulative steroid dose or post-transplant cytomegalovirus viremia (p = 0.9, 0.6 and 0.7, respectively). CONCLUSIONS: This study identifies hypomagnesemia as a significant independent risk factor for the development of NODAT in pediatric renal transplant recipients. Given the clear association between hypomagnesemia and NODAT in both adults and children following renal transplantation, further studies are merited to clarify the etiology of this association and to examine the effect of magnesium supplementation on NODAT.


Asunto(s)
Diabetes Mellitus/etiología , Trasplante de Riñón/efectos adversos , Deficiencia de Magnesio/complicaciones , Adolescente , Índice de Masa Corporal , Niño , Preescolar , Infecciones por Citomegalovirus/sangre , Infecciones por Citomegalovirus/complicaciones , Femenino , Humanos , Inmunosupresores/uso terapéutico , Lactante , Deficiencia de Magnesio/sangre , Masculino , Complicaciones Posoperatorias , Estudios Retrospectivos , Factores de Riesgo , Esteroides/efectos adversos , Esteroides/uso terapéutico , Tacrolimus/uso terapéutico , Receptores de Trasplantes
5.
Transplantation ; 92(3): 328-33, 2011 Aug 15.
Artículo en Inglés | MEDLINE | ID: mdl-21685826

RESUMEN

BACKGROUND: Studies have identified solid organ transplant recipients who remain asymptomatic despite maintaining chronic high Epstein-Barr virus (EBV) viral loads. We examined clinical manifestations, EBV gene expression, human leukocyte antigen (HLA) alleles, and specific T-cell responses to EBV infection in pediatric renal transplant patients. METHODS: Seventeen pediatric renal transplant patients were categorized according to EBV viral load into those with chronic high viral loads (CHL) and recipients who resolve EBV infection (REI). EBV gene expression was analyzed using real-time PCR assays and EBV-specific T cells were analyzed by flow cytometry. RESULTS: EBV gene, EBV-encoded small RNA 1, was expressed at significantly higher levels in CHL compared with EBV seropositive controls (P=0.005) and raised compared with REI. BamHI A right-ward transcripts were also expressed at higher levels in CHL patients (P=0.03) than in REI. Expression of latent genes, EBNA1, LMP1, LMP2, and lytic gene BZLF1 were restricted to the CHL group with viral gene expression varying over time. HLA-A*02 allele expression was predominant in CHL patients (80%) and GLC lytic-specific cytotoxic T-lymphocytes were absent. In contrast, HLA-B*08 allele expression was prevalent in REI patients (71%) and RAK lytic cytotoxic T-lymphocytes were detected in all patients. CONCLUSION: EBV gene expression in CHL carriers differs from those that resolve infection and should be interpreted alongside HLA polymorphisms.


Asunto(s)
Infecciones por Virus de Epstein-Barr/genética , Infecciones por Virus de Epstein-Barr/inmunología , Antígenos HLA/genética , Herpesvirus Humano 4/genética , Trasplante de Riñón , Carga Viral/genética , Adolescente , Linfocitos T CD8-positivos/inmunología , Linfocitos T CD8-positivos/virología , Niño , Preescolar , Enfermedad Crónica , Femenino , Perfilación de la Expresión Génica , Regulación Viral de la Expresión Génica , Antígenos HLA/inmunología , Humanos , Lactante , Masculino , Complicaciones Posoperatorias/genética , Complicaciones Posoperatorias/inmunología , Complicaciones Posoperatorias/virología , ARN Viral/genética , Recurrencia , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Carga Viral/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...